139.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$140.81
Aprire:
$140.28
Volume 24 ore:
461.55K
Relative Volume:
0.27
Capitalizzazione di mercato:
$39.52B
Reddito:
$6.79B
Utile/perdita netta:
$1.22B
Rapporto P/E:
32.70
EPS:
4.2644
Flusso di cassa netto:
$1.09B
1 W Prestazione:
+0.61%
1M Prestazione:
+10.53%
6M Prestazione:
+30.35%
1 anno Prestazione:
-3.63%
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Confronta A con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
A
Agilent Technologies Inc
|
139.41 | 39.92B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
TMO
Thermo Fisher Scientific Inc
|
532.37 | 202.47B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.13 | 146.76B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
627.57 | 50.40B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
IQV
Iqvia Holdings Inc
|
204.15 | 34.10B | 15.70B | 1.24B | 2.01B | 6.9036 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-08-28 | Iniziato | Wells Fargo | Overweight |
2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2024-06-03 | Ripresa | Jefferies | Hold |
2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
2023-12-13 | Iniziato | Wolfe Research | Outperform |
2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
2023-11-17 | Downgrade | UBS | Buy → Neutral |
2023-09-28 | Iniziato | Bernstein | Mkt Perform |
2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
2023-05-24 | Reiterato | Barclays | Equal Weight |
2023-05-24 | Reiterato | BofA Securities | Buy |
2023-05-24 | Reiterato | Citigroup | Neutral |
2023-05-24 | Reiterato | Credit Suisse | Outperform |
2023-05-24 | Reiterato | Evercore ISI | Outperform |
2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-05-24 | Reiterato | Robert W. Baird | Outperform |
2023-05-24 | Reiterato | SVB Securities | Outperform |
2023-05-24 | Reiterato | Stifel | Hold |
2023-05-24 | Reiterato | TD Cowen | Outperform |
2023-05-24 | Reiterato | Wells Fargo | Overweight |
2023-05-11 | Iniziato | Barclays | Equal Weight |
2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-07-20 | Iniziato | UBS | Buy |
2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-02-23 | Reiterato | BofA Securities | Buy |
2022-02-23 | Reiterato | Citigroup | Buy |
2022-02-23 | Reiterato | Cowen | Outperform |
2022-02-23 | Reiterato | Evercore ISI | Outperform |
2022-02-23 | Reiterato | Stifel | Hold |
2022-02-23 | Reiterato | Wells Fargo | Overweight |
2021-11-23 | Reiterato | BofA Securities | Buy |
2021-11-23 | Reiterato | Cowen | Outperform |
2021-11-23 | Reiterato | Stifel | Hold |
2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-12-02 | Iniziato | Goldman | Buy |
2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
2020-09-30 | Iniziato | Atlantic Equities | Neutral |
2020-08-19 | Reiterato | BofA Securities | Neutral |
2020-08-19 | Reiterato | Citigroup | Neutral |
2020-08-19 | Reiterato | Jefferies | Buy |
2020-08-19 | Reiterato | Robert W. Baird | Outperform |
2020-08-19 | Reiterato | SVB Leerink | Outperform |
2020-08-19 | Reiterato | Stifel | Hold |
2020-08-19 | Reiterato | Wells Fargo | Overweight |
2020-02-24 | Downgrade | Needham | Buy → Hold |
2020-01-08 | Iniziato | Wells Fargo | Overweight |
2020-01-07 | Iniziato | Citigroup | Neutral |
2019-11-26 | Reiterato | Needham | Buy |
2019-11-15 | Iniziato | Stifel | Hold |
2019-10-18 | Downgrade | UBS | Buy → Neutral |
2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies (A) Receives Raised Price Target from JP Mo - GuruFocus
JPMorgan Adjusts PT on Agilent Technologies to $165 From $155, Maintains Overweight Rating - MarketScreener
How currency fluctuations impact Agilent Technologies Inc. stockQuarterly Portfolio Report & Real-Time Volume Analysis - newser.com
What technical models suggest about Agilent Technologies Inc.’s comebackJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Visual analytics tools that track Agilent Technologies Inc. performance2025 Top Decliners & Safe Capital Growth Tips - newser.com
Key resistance and support levels for Agilent Technologies Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-09 03:50:55 - newser.com
Custom strategy builders for tracking Agilent Technologies Inc.Analyst Downgrade & High Yield Stock Recommendations - newser.com
Best data tools to analyze Agilent Technologies Inc. stock2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
Risk adjusted return profile for Agilent Technologies Inc. analyzedWeekly Investment Report & Verified Stock Trade Ideas - newser.com
Agilent Technologies (A) Receives Boost After UBS Upgrade - GuruFocus
Agilent upgraded to Buy at UBS on growth outlook - MSN
UBS Upgrades Agilent Technologies to Buy From Neutral, Raises Price Target to $170 From $130 - MarketScreener
UBS Upgrades Agilent Technologies (A) - Nasdaq
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows - the-scientist.com
UBS upgrades Agilent on China, pharma lab demand; sees 20%+ upside By Investing.com - Investing.com Nigeria
UBS upgrades Agilent on China, pharma lab demand; sees 20%+ upside - Investing.com Canada
Agilent Technologies (A) Receives Upgrade from UBS with Raised P - GuruFocus
This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Agilent Technologies (A) Receives 'Buy' Rating from Rothschild & Co | A Stock News - GuruFocus
Rothschild & Co Redburn Initiates Agilent Technologies at Buy With $165 Price Target - MarketScreener
Rothschild Redburn initiates Agilent stock with Buy rating, $165 target - Investing.com
UBS upgrades Agilent stock rating to Buy on growth leadership potential - Investing.com
Evercore ISI Group Maintains Agilent Technologies (A) In-Line Recommendation - Nasdaq
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years - Benzinga
Agilent Technologies Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Agilent Technologies Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Agilent Technologies (A) Receives Updated Price Target from Ever - GuruFocus
Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $128, Maintains In Line Rating - MarketScreener
Agilent Technologies price stallsForecast today07-10-2025 - Economies.com
Inert HPLC columns enhance biotherapeutic analysis - Labmate Online
Advanced SORS systems transform airport security screening - Labmate Online
Why Agilent Technologies Inc. stock is a must watch in 2025Earnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Real time social sentiment graph for Agilent Technologies Inc.Quarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com
Agilent Technologies, Inc. $A Shares Acquired by Fenimore Asset Management Inc - MarketBeat
Reversal indicators forming on Agilent Technologies Inc. stockQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
How to recover losses in Agilent Technologies Inc. stockJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
Is Agilent Technologies Inc. stock a buy before product launchesWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Will Agilent Technologies Inc. stock profit from AI boomTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Agilent Technologies, Inc. $A Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
Pure Financial Advisors LLC Makes New Investment in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A): Valuation in Focus Following Expansion Into AI Diagnostics, Biopharma Tools, and Security Solutions - Sahm
Penobscot Investment Management Company Inc. Lowers Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Janney Montgomery Scott LLC Has $14.17 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (NYSE:A) Upgraded at Wall Street Zen - MarketBeat
Jefferies Lifts Agilent Technologies' Price Target to $130 From $120 - MarketScreener
Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Zenopa
Agilent and Chungnam National University to build Open Biopharma Research Hub in South Korea - BioSpectrum Asia
Can Agilent Technologies' (A) AI Moves Redefine Its Edge in Diagnostics and Security Markets? - Sahm
How Agilent Technologies Inc. stock benefits from tech adoption2025 Historical Comparison & Reliable Price Breakout Signals - newser.com
Is Agilent Technologies Inc. (AG8) stock resilient in recession scenariosEarnings Growth Report & Growth Focused Stock Pick Reports - newser.com
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):